Good News for Your CHE Patients: Delgocitinib Cream (Anzupgo, LEO Pharma, Inc.) is Now Available in the U.S.
Delgocitinib cream (Anzupgo, LEO Pharma, Inc.) is now available for the treatment of adults with moderate-to-severe chronic hand eczema (CHE) in the U.S. Delgocitinib cream is a steroid-free, topical pan-Janus kinase (JAK) inhibitor approved for adult patients whose CHE is not well-controlled or cannot use topical corticosteroids. Based on Two Identical Studies The U.S. Food […]